| Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells H Jiang, Y Ren, EY Yuen, P Zhong, M Ghaedi, Z Hu, G Azabdaftari, ... Nature communications 3 (1), 668, 2012 | 289 | 2012 |
| Characterization of background noise in capture-based targeted sequencing data G Park, JK Park, SH Shin, HJ Jeon, NKD Kim, YJ Kim, HT Shin, E Lee, ... Genome biology 18, 1-13, 2017 | 62 | 2017 |
| Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients G Park, JK Park, DS Son, SH Shin, YJ Kim, HJ Jeon, J Lee, WY Park, ... Scientific reports 8 (1), 11631, 2018 | 55 | 2018 |
| The minimal amount of starting DNA for Agilent’s hybrid capture-based targeted massively parallel sequencing J Chung, DS Son, HJ Jeon, KM Kim, G Park, GH Ryu, WY Park, D Park Scientific reports 6 (1), 26732, 2016 | 46 | 2016 |
| Analyzing somatic genome rearrangements in human cancers by using whole-exome sequencing L Yang, MS Lee, H Lu, DY Oh, YJ Kim, D Park, G Park, X Ren, CA Bristow, ... The American Journal of Human Genetics 98 (5), 843-856, 2016 | 41 | 2016 |
| Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer G Park, TH Kim, HO Lee, JA Lim, JK Won, HS Min, KE Lee, DJ Park, ... Endocrine-related cancer 22 (1), 55-63, 2015 | 36 | 2015 |
| Circulating tumor DNA shows variable clonal response of breast cancer during neoadjuvant chemotherapy JY Kim, D Park, DS Son, SJ Nam, SW Kim, HH Jung, YJ Kim, G Park, ... Oncotarget 8 (49), 86423, 2017 | 19 | 2017 |
| Artificial intelligence–powered hematoxylin and eosin analyzer reveals distinct immunologic and mutational profiles among immune phenotypes in non–small-cell lung cancer J Park, HG Cho, J Park, G Lee, HS Kim, K Paeng, S Song, G Park, CY Ock, ... The American Journal of Pathology 192 (4), 701-711, 2022 | 7 | 2022 |
| Artificial intelligence-powered whole-slide image analyzer reveals a distinctive distribution of tumor-infiltrating lymphocytes in neuroendocrine neoplasms HG Cho, SI Cho, S Choi, W Jung, J Shin, G Park, J Moon, M Ma, H Song, ... Diagnostics 12 (10), 2340, 2022 | 3 | 2022 |
| Deep learning model improves tumor-infiltrating lymphocyte evaluation and therapeutic response prediction in breast cancer S Choi, SI Cho, W Jung, T Lee, SJ Choi, S Song, G Park, S Park, M Ma, ... NPJ Breast Cancer 9 (1), 71, 2023 | 2 | 2023 |
| Deep learning-based ensemble model using hematoxylin and eosin (H&E) whole slide images (WSIs) for the prediction of MET mutations in non-small cell lung cancer (NSCLC). YL Choi, S Park, HA Jung, JM Sun, SH Lee, JS Ahn, MJ Ahn, T Lee, ... Journal of Clinical Oncology 41 (16_suppl), e13578-e13578, 2023 | 2 | 2023 |
| Papillary thyroid cancer immune phenotypes via tumor-infiltrating lymphocyte spatial analysis M Nam, W Yang, HS Kim, J Park, G Park, S Kim, S Song, CY Ock, ... Endocrine-related cancer 30 (9), 2023 | 1 | 2023 |
| Artificial intelligence–powered tumor-infiltrating lymphocytes analyzer to reveal distinct immune landscapes in breast cancer by molecular subtype and HER2 score. S Shin, SY Cho, EY Cho, SW Kim, M Jung, SG Song, Y Lim, SI Cho, S Kim, ... Journal of Clinical Oncology 41 (16_suppl), 1049-1049, 2023 | 1 | 2023 |
| Correlation of fragmented pattern of tumor mass captured by artificial intelligence (AI)-powered whole-slide image (WSI) analysis with biased fibroblast expansion over tumor … S Kim, S Song, G Park, S Kim, H Song, M Kang, S Pereira, CY Ock Journal of Clinical Oncology 41 (16_suppl), e14657-e14657, 2023 | 1 | 2023 |
| 1285 Spatial analysis of tumor-infiltrating lymphocytes (TILs) based on HER2 expression across multiple cancer types S Kim, S Kim, Y Lim, G Park, S Song, H Song, S Park, J Ryu, S Pereira, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker–driven learning framework SH Rossi, I Newsham, S Pita, K Brennan, G Park, CG Smith, RP Lach, ... Science Advances 8 (39), eabn9828, 2022 | 1 | 2022 |
| An artificial intelligence‐powered PD‐L1 combined positive score (CPS) analyser in urothelial carcinoma alleviating interobserver and intersite variability KS Lee, E Choi, SI Cho, S Park, J Ryu, AV Puche, M Ma, J Park, W Jung, ... Histopathology, 2024 | | 2024 |
| Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 cases M Jung, SG Song, SI Cho, S Shin, T Lee, W Jung, H Lee, J Park, S Song, ... Breast Cancer Research 26 (1), 31, 2024 | | 2024 |
| Reply to Behnam Shakiba's Letter to the Editor re: Emilien Seizilles de Mazancourt, Juliette Cotte, Caroline Plassais, et al. Sexual and Moral Harassment of French Urologists … ES de Mazancourt, K Kaulanjan European urology, S0302-2838 (24) 00072-1, 2024 | | 2024 |
| Ultra-sensitive detection of circulating tumour DNA enriches for patients with greater risk of recurrence in clinically localised prostate cancer B Pope, G Park, E Lau, J Belic, R Lach, A George, P McCoy, A Nguyen, ... European Urology, 2024 | | 2024 |
